4-[[4-[2-(2-amino-3-pyridinyl)imidazo[4,5-b]pyridin-3-yl]phenyl]methylamino]pyrimidine-2-carbonitrile
C23H17N9 — CID 171495410
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[[4-[2-(2-amino-3-pyridinyl)imidazo[4,5-b]pyridin-3-yl]phenyl]methylamino]pyrimidine-2-carbonitrile
4-[[4-[2-(2-amino-3-pyridinyl)imidazo[4,5-b]pyridin-3-yl]phenyl]methylamino]pyrimidine-2-carbonitrile (PubChem CID 171495410) has the molecular formula C23H17N9 and a molecular weight of 419.45 g/mol. Its IUPAC name is 4-[[4-[2-(2-amino-3-pyridinyl)imidazo[4,5-b]pyridin-3-yl]phenyl]methylamino]pyrimidine-2-carbonitrile.
Molecular Properties
| Compound Name | 4-[[4-[2-(2-amino-3-pyridinyl)imidazo[4,5-b]pyridin-3-yl]phenyl]methylamino]pyrimidine-2-carbonitrile |
|---|---|
| PubChem CID | 171495410 |
| Molecular Formula | C23H17N9 |
| Molecular Weight | 419.45 g/mol |
| Exact Mass | 419.16 |
| IUPAC Name | 4-[[4-[2-(2-amino-3-pyridinyl)imidazo[4,5-b]pyridin-3-yl]phenyl]methylamino]pyrimidine-2-carbonitrile |
| SMILES | N#Cc1nccc(NCc2ccc(-n3c(-c4cccnc4N)nc4cccnc43)cc2)n1 |
| InChI | InChI=1S/C23H17N9/c24-13-20-26-12-9-19(31-20)29-14-15-5-7-16(8-6-15)32-22(17-3-1-10-27-21(17)25)30-18-4-2-11-28-23(18)32/h1-12H,14H2,(H2,25,27)(H,26,29,31) |
| InChIKey | SMQIBXIOVOJWOG-UHFFFAOYSA-N |
| XLogP | 3.34 |
| TPSA | 131.22 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 419.45 |
| LogP ≤ 5 | 3.34 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171495410 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.